JCB Laboratories has been at the forefront of shaping industry standards in sterile preparations for nearly two decades, and was one of the first companies in the country to register with the FDA. In December, 2013, as a forward-thinking pharmaceutical supplier, global custom pharmaceutical care leader, Fagron, recognized the opportunity to serve their customers better by acquiring JCB Laboratories. Building off JCB’s experience, Fagron developed Fagron Sterile Service (FSS), constructing a state-of-the-art manufacturing facility JCB and FSS, are FDA-registered, 503B Human Drug Outsourcing Facilities that manufacture sterile products. JCB and FSS formulate products with unique qualities specific to customer needs; like preparing preservative-free products, offering various product strengths and sizes, or simply providing a product otherwise unavailable due to manufacturer back order or discontinuation.